JACC. Case reports · 2025
Durable Long-Term Outcomes After Early Transcatheter Arterialization of the Deep Veins.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Patel Avkash, Shishehbor Mehdi H
Аннотация
BACKGROUND: Up to 20% of patients with chronic limb-threatening ischemia (CLTI) are not eligible for conventional revascularization options despite having severe symptoms of nonhealing ulcers and gangrene. Transcatheter arterialization of the deep veins (TADV) has shown promising results in this challenging subset of patients.
CASE SUMMARY: We present the long-term outcomes of 4 patients with no-option CLTI who were at risk of major below-the-knee amputation and were treated with TADV with the LimFlow System (Inari Medical).
DISCUSSION: The PROMISE trials have reported positive outcomes at 12 months after TADV, and the long-term durability of TADV remains of great interest. The patients herein underwent successful TADV, with durable limb salvage through follow-up extending up to 8 years.
TAKE-HOME MESSAGE: TADV with the LimFlow System provides durable limb salvage in no-option CLTI patients, with observed long-term wound healing and symptom healing.
CASE SUMMARY: We present the long-term outcomes of 4 patients with no-option CLTI who were at risk of major below-the-knee amputation and were treated with TADV with the LimFlow System (Inari Medical).
DISCUSSION: The PROMISE trials have reported positive outcomes at 12 months after TADV, and the long-term durability of TADV remains of great interest. The patients herein underwent successful TADV, with durable limb salvage through follow-up extending up to 8 years.
TAKE-HOME MESSAGE: TADV with the LimFlow System provides durable limb salvage in no-option CLTI patients, with observed long-term wound healing and symptom healing.